Registration Document 2005 - Total.com

7. Other income and other expense
Appendix 1 – Consolidated financial statements
Notes to the consolidated financial statements 9
As of December 31, (in millions of euros) 2005 2004
Gains (losses) on sales of assets 99 3,139
Foreign exchange gains 78 -
Other income 177 3,139
Foreign exchange losses - (75)
Amortization of other intangible assets (excl. leasehold rights) (241) (473)
Toulouse-AZF plant explosion (100) (150)
Other (421) (499)
Other expense (762) (1,197)
Amortization of other intangible assets includes 54 million euros
of goodwill impairment losses for 2005.
In 2005, the “Other” heading mainly includes an allowance of
292 million euros for litigation reserves in connection with antitrust
investigations, as described in note 30 to the consolidated financial
statements “Other risks and contingent liabilities”.
In 2004, the deterioration of the economic cycle generated
impairment losses on intangible assets in the Chemicals segment.
As a consequence, an impairment loss of 201 million euros had
been recorded in 2004 to adjust the carrying amount of the
intangible assets to their recoverable amount.
8. Other financial income and expense
The gains (losses) on sales of assets included a pre-tax dilution gain
on the Sanofi-Aventis merger of 2,969 million euros in 2004.
In 2004, the “Other” heading mainly included early retirement plans
and restructuring costs for 165 million euros, and other allowances
for various litigation reserves for 82 million euros.
As of December 31, (in millions of euros) 2005 2004
Dividend income on non-consolidated companies 171 164
Capitalized financial expenses 102 35
Other 132 134
Other financial income 405 333
Accretion of asset retirement obligation (162) (143)
Other (107) (92)
Other financial expense (269) (235)
TOTAL - Registration Document 2005
187